External / Related evidence

Preservation, perfusion and xenotransplantation.

Ten external liver, kidney and lung studies. None evaluated BHOC.

External evidence. Results belong to the study and intervention named in each record. They do not establish BHOC efficacy or a transplant indication. How we classify evidence →
01 / Liver

Hypothermic Oxygenated Perfusion Versus Static Cold Storage in Liver Transplantation: A Meta-Analysis of Randomized Trials

Year:
2026
Design:
Meta-analysis of randomized trials
Modality:
HOPE / preservation

Population / data: 8 randomized trials; 984 adult liver transplant recipients

Published signal: HOPE was associated with lower early allograft dysfunction, primary non-function, major complications and biliary complications than static cold storage; one-year graft survival was comparable.

Limit: HOPE was compared with static cold storage, not with an oxygen-carrier intervention.

DOI: 10.1111/ctr.70676 ↗ · PubMed ↗

02 / Kidney

Machine Perfusion Parameters and 1-Year Outcomes in High KDPI Kidney Transplantation: A Single-Center Cohort Study

Year:
2026
Design:
Single-center retrospective cohort
Modality:
Hypothermic machine perfusion

Population / data: 71 recipients of kidneys with KDPI ≥85

Published signal: Pre-specified machine-perfusion flow and resistance groups did not show statistically significant differences in one-year renal function, graft survival or patient survival.

Limit: Observational, single-center evidence; no oxygen-carrier intervention was tested.

DOI: 10.1016/j.transproceed.2026.07.036 ↗ · PubMed ↗

03 / Lung

Early-to-Midterm Outcomes of Lung Transplantation Following Procurement with Thoracoabdominal Regional Perfusion: An OPTN Analysis

Year:
2026
Design:
OPTN retrospective analysis
Modality:
TA-NRP / procurement

Population / data: DCD lung transplantation; 1364 standard rapid recovery and 261 TA-NRP recipients

Published signal: One- and three-year survival were comparable. After adjustment, TA-NRP recipients had lower odds of ECMO use at 72 hours.

Limit: Registry analysis; no oxygen-carrier comparison.

DOI: 10.1016/j.healun.2026.09.005 ↗ · PubMed ↗

04 / Liver

Real-World Analysis of Hypothermic Oxygenated Perfusion and Normothermic Machine Perfusion in Liver Transplantation: An International Cohort Study

Year:
2026
Design:
International real-world cohort
Modality:
HOPE vs NMP

Population / data: 954 NMP-treated and 1202 HOPE-treated liver grafts

Published signal: The study compared contemporary HOPE and NMP practice across international cohorts with substantial baseline donor-risk differences and risk-adjusted analyses.

Limit: Non-randomized comparison with baseline donor-risk differences.

DOI: 10.1097/SLA.0000000000007195 ↗ · PubMed ↗

05 / Liver

Real-World Use of Normothermic Machine Perfusion in Liver Transplantation: A Multi-Institutional Experience From the National Organ Perfusion Registry

Year:
2026
Design:
Multicenter registry study
Modality:
Normothermic machine perfusion

Population / data: 545 NMP liver transplants across nine U.S. centers

Published signal: The registry described diverse NMP practice and reported a 90-day death-censored graft failure rate of 1.7%.

Limit: Descriptive registry evidence without a randomized control group.

DOI: 10.1111/ctr.70664 ↗ · PubMed ↗

06 / Kidney

Results of Two Cases of Pig-to-Human Kidney Xenotransplantation

Montgomery RA, Stern JM, Lonze BE, et al. · NEJM · 19 May 2022

Design:
Two-case human decedent study
Observation:
54 hours

Published signal: Short-term xenograft function without biopsy signs of hyperacute or antibody-mediated rejection during the observation window.

Limit: Short-term decedent study; it cannot establish outcomes in living recipients.

Read the focused evidence brief →

DOI: 10.1056/NEJMoa2120238 ↗ · PubMed / full author list ↗

07 / Kidney

Physiology and immunology of a pig-to-human decedent kidney xenotransplant

Montgomery RA, Stern JM, Fathi F, Suek N, et al. · Nature · First online 13 November 2025; issue 5 February 2026

Design:
Single-recipient human decedent study
Observation:
61 days

Published signal: Dialysis independence; rejection on day 33, reported as reversed after treatment.

Limit: Rejection occurred on day 33; one decedent study cannot establish long-term outcomes in living recipients.

Read the focused evidence brief →

DOI: 10.1038/s41586-025-09847-6 ↗ · PubMed / full author list ↗

Corrections: Publisher, 12 February 2026 · Author, 4 June 2026. Amendments are not counted as separate studies.

08 / Kidney

Storage under hypoxia improves the ability of red cells to release oxygen in ex vivo-perfused human kidneys

Rabcuka J, Fallon J, Meli A, et al. · Blood Red Cells & Iron · March 2026 · 2(1):100038

Design:
Experimental ex vivo human organ study
Modality:
Normothermic kidney perfusion with stored donor RBCs

Published signal: Switching to hypoxically stored RBCs reversibly increased renal respiratory rate by approximately 20% and oxygen diffusion capacity by approximately 70%.

Limit: Isolated-organ experiment. Patient transfusion outcomes and post-transplant outcomes were not tested; no BHOC intervention was used.

Read the functional-quality evidence brief →

DOI: 10.1016/j.brci.2025.100038 ↗ · Original publisher record ↗

09 / Liver

Ex Vivo Normothermic Machine Perfusion Is Safe, Simple, and Reliable: Results From a Large Animal Model

Nassar A, et al. · Surgical Innovation · February 2015; first online 2 April 2014

Design:
Preclinical porcine ex vivo study with transplant simulation
Modality:
Normothermic machine perfusion

Population / data: 20 pig livers: normothermic perfusion (n=15) or cold storage (n=5), followed by 24-hour transplant simulation.

Published signal: No system failures were reported; functional and histological findings favored normothermic perfusion in this model.

Research relevance: Methodological context for evaluating perfusion-system performance alongside organ outcomes.

Limit: Ex vivo simulation, without transplantation into recipient animals. Neither BHOC nor clinical safety was established.

Added 13 October 2026 · External preclinical evidence

DOI: 10.1177/1553350614528383 ↗ · PubMed / authors ↗

Read the research perspective ↗

10 / Liver

A Small Animal Model of Ex Vivo Normothermic Liver Perfusion

Beal EW, et al. · Journal of Visualized Experiments · 27 June 2018

Design:
Preclinical rat ex vivo methods study
Modality:
Normothermic ex vivo perfusion with PEG-catalase

Population / data: Rat livers, three animals per group; base perfusate compared with PEG-catalase supplementation.

Published signal: PEG-catalase reduced perfusate ALT at later time points. Tissue ATP, GSH, MDA and apoptosis were also assessed.

Research relevance: A small-animal platform for testing perfusate additives against defined tissue endpoints.

Limit: Small exploratory groups and no transplantation after perfusion. Post-transplant function and BHOC benefit were not established.

Added 13 October 2026 · External preclinical evidence

DOI: 10.3791/57541 ↗ · PubMed / authors ↗ · Full text ↗

Read the research perspective ↗

Ten study records · Source data (JSON) · Updated .

Historical HBOC publications

The 53-record catalogue remains in the central BHOC Platform.

Open historical catalogue ↗